In vitro and in vivo biomaterial studies

Pre-Clinical Biomaterials

Investigate biomaterial safety, tissue integration and functional performance through tailored preclinical studies.

Detailed specifications
Test articles3D-bioprinted scaffolds, hydrogel patches, implantable regenerative constructs and bioengineered medical devices
Safety studiesBiocompatibility, toxicity, tolerance and immunological response
Functional endpointsTissue integration, neovascularization, mechanical stability, degradation kinetics and long-term implant function
Study servicesIn vitro and in vivo toxicity, dermal/ocular tolerance, pharmacodynamics, test-product administration and specimen procurement, as listed in the catalogue
ProceduresLaparoscopy, endoscopy, interventional radiology and microsurgery
Robotic-assisted surgeryCatalogue lists DA VINCI XI, SYMANI and VERSIUS systems
ImagingHalf-arc fluoroscopy, ultrasound and 3 Tesla MRI
Additional capabilities3D printing for prototyping and simulation
Model optionsCatalogue lists rodents, lagomorphs, swine, sheep and canine models; selection depends on the study
Quality documentationCatalogue reports GLP-certified services, ISO 9001:2015 quality and AAALAC-accredited animal care. Confirm the applicable facility, scope and current documentation with MAKBY.
Study specificationEndpoints, controls, sample numbers, observation periods and reporting scope are defined for the selected technology and development question

Methods, deliverables & evidence

  • Studies can evaluate tissue integration, vascularization, material degradation and functional performance
  • Study findings can inform biomaterial design refinement
  • Catalogue describes structured studies aligned with regulatory expectations; requirements and suitability must be reviewed for the particular technology

Technical catalogue

Specifications summarized from the October 2026 tissue engineering catalogue, printed page 26. Confirm the selected configuration, compatibility and experimental conditions with MAKBY.